Ignite Creation Date:
2025-12-25 @ 2:59 AM
Ignite Modification Date:
2025-12-26 @ 1:40 AM
Study NCT ID:
NCT00298233
Status:
COMPLETED
Last Update Posted:
2014-06-06
First Post:
2006-03-01
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
High-Dose Versus Standard-Dose Oseltamivir to Treat Severe Influenza and Avian Influenza
Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-02
Start Date Type:
None
Primary Completion Date:
2010-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2010-01
Completion Date Type:
ACTUAL
First Submit Date:
2006-03-01
First Submit QC Date:
None
Study First Post Date:
2006-03-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-01-17
Results First Submit QC Date:
None
Results First Post Date:
2014-05-22
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-05-26
Last Update Post Date:
2014-06-06
Last Update Post Date Type:
ESTIMATED